Clinical trials
Recruiting Lung Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 10 |
| 2025 | 9 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Johns Hopkins University | 3 |
| AstraZeneca | 2 |
| BioNTech SE | 2 |
| Eli Lilly and Company | 2 |
| Iovance Biotherapeutics, Inc. | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| National Institutes of Health Clinical Center (CC) | 2 |
| Albert Einstein College of Medicine | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 57 |
| Respiratory Tract Diseases | 18 |
| Lung Neoplasms | 12 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Neoplasms | 8 |
| Thoracic Neoplasms | 8 |
| COVID-19 | 7 |
| Infections | 7 |
| Lung Diseases, Interstitial | 7 |
| Neoplasms by Site | 7 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.